Treovir, LLC   Report issue

For profit Phase 2
Founded: Philadelphia PA United States (2019)

Organization Overview

First Clinical Trial
2020
NCT04482933
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Treovir, LLC